AMPK: a balancer of the renin–angiotensin system
Author(s) -
Jia Liu,
Xuan Li,
Qingguo Lü,
Di Ren,
Xiaodong Sun,
Thomas Rousselle,
Ji Li,
Jiyan Leng
Publication year - 2019
Publication title -
bioscience reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.938
H-Index - 77
eISSN - 1573-4935
pISSN - 0144-8463
DOI - 10.1042/bsr20181994
Subject(s) - ampk , autophagy , renin–angiotensin system , protein kinase a , diabetes mellitus , amp activated protein kinase , signal transduction , pi3k/akt/mtor pathway , microbiology and biotechnology , insulin resistance , hyperlipidemia , biology , endocrinology , apoptosis , kinase , medicine , blood pressure , biochemistry
The renin-angiotensin system (RAS) is undisputedly well-studied as one of the oldest and most critical regulators for arterial blood pressure, fluid volume, as well as renal function. In recent studies, RAS has also been implicated in the development of obesity, diabetes, hyperlipidemia, and other diseases, and also involved in the regulation of several signaling pathways such as proliferation, apoptosis and autophagy, and insulin resistance. AMP-activated protein kinase (AMPK), an essential cellular energy sensor, has also been discovered to be involved in these diseases and cellular pathways. This would imply a connection between the RAS and AMPK. Therefore, this review serves to draw attention to the cross-talk between RAS and AMPK, then summering the most recent literature which highlights AMPK as a point of balance between physiological and pathological functions of the RAS.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom